Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,230 public trials 3,233 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

NCT05152147

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Hospital de Gastroenterología Dr Bonorino Udaondo Buenos Aires, Argentina
  • Instituto de Investigaciones Metabólicas - IDIM Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires Buenos Aires, Argentina
  • Fundación Centro de Medicina Nuclear y Molecular ER Córdoba, Argentina
View all 227 locations
View Trial Details
Active, Not Recruiting

Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases

NCT03599752

Conditions
Colonic Diseases, Colorectal Adenocarcinoma, Colorectal Carcinoma Metastatic in the Lung, +14 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • Baylor Colllege of Medicine Houston, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

NCT04550494

Conditions
Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +64 more
Locations
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Active, Not Recruiting

A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).

NCT03653507

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +13 more
Locations
  • Pacific Cancer Care Monterey, California, United States
  • University of Kansas Cancer Center and Medical Pavilion Fairway, Kansas, United States
  • Ochsner Clinic CCOP New Orleans, Louisiana, United States
  • New Mexico Oncology Hematology Albuquerque, New Mexico, United States
View all 165 locations
View Trial Details

Related conditions